We provide you with 20 years of free, institutional-grade data for ABVX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ABVX. Explore the full financial landscape of ABVX stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|
The information provided in this report about ABVX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
ABIVAX Société Anonyme(NASDAQ:ABVX) 
ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases. The company is evaluating its lead drug candidate, obefazimod, in P...
Website: https://www.abivax.com/
Founded: 2013
IPO Price: $11.6 (Oct 20, 2023)
Sector: TECHNOLOGY
Industry: GENERAL
Share this website to your friends